| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |